[Federal Register: November 6, 2009 (Volume 74, Number 214)] [Notices] [Page 57460] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr06no09-38] ----------------------------------------------------------------------- DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Methods and Composition for Live Bubonic Plague Vaccine Based on Yersinia Pestis * * * Gene Deletion AGENCY: Department of the Army, DoD. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/242,113 entitled ``Methods and Composition for Live Bubonic Plague Vaccine Based On Yersinia Pestis * * * Gene Deletion,'' filed September 14, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034. SUPPLEMENTARY INFORMATION: The invention relates to the creation of live vaccines by removing a specific gene, which is essential for virulence (the ability of a pathogen to make sick or kill a human or an animal) from a pathogen. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. E9-26790 Filed 11-5-09; 8:45 am] BILLING CODE 3710-08-P
Justia Lawyer, Legal Aid & Services Directory: Military Lawyers